Novartis Aktie
110,95
EUR
-1,15
EUR
-1,03
%
103,16
CHF
-0,92
CHF
-0,88
%
Werbung
Novartis Aktie Analyse
| 22.03.24 | Novartis Buy | Deutsche Bank AG | |
| 07.02.24 | Novartis Buy | Deutsche Bank AG | |
| 07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 06.02.24 | Novartis Underweight | Barclays Capital | |
| 06.02.24 | Novartis Buy | UBS AG | |
| 05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.02.24 | Novartis Buy | Deutsche Bank AG | |
| 31.01.24 | Novartis Kaufen | DZ BANK | |
|
Werbung
|
|||
| 31.01.24 | Novartis Buy | UBS AG | |
| 31.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.01.24 | Novartis Buy | UBS AG | |
| 16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG | |
| 03.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 21.12.23 | Novartis Underweight | Barclays Capital | |
| 19.12.23 | Novartis Buy | Deutsche Bank AG | |
| 05.12.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.11.23 | Novartis Buy | Deutsche Bank AG | |
| 29.11.23 | Novartis Underweight | Barclays Capital | |
| 28.11.23 | Novartis Neutral | UBS AG | |
| 28.11.23 | Novartis Buy | Jefferies & Company Inc. | |
| 27.11.23 | Novartis Buy | Deutsche Bank AG | |
| 26.10.23 | Novartis Buy | Deutsche Bank AG | |
| 24.10.23 | Novartis Neutral | UBS AG | |
| 24.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 23.10.23 | Novartis Underweight | Barclays Capital | |
| 19.10.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.10.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.10.23 | Novartis Buy | Deutsche Bank AG | |
| 04.10.23 | Novartis Neutral | UBS AG | |
| 04.10.23 | Novartis Buy | Deutsche Bank AG | |
| 03.10.23 | Novartis Buy | Deutsche Bank AG | |
| 26.09.23 | Novartis Buy | Deutsche Bank AG | |
| 25.09.23 | Novartis Equal-weight | Morgan Stanley | |
| 22.09.23 | Novartis Buy | Deutsche Bank AG | |
| 08.09.23 | Novartis Buy | Deutsche Bank AG | |
| 05.09.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.09.23 | Novartis Buy | Deutsche Bank AG | |
| 31.08.23 | Novartis Buy | Deutsche Bank AG | |
| 31.08.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 15.08.23 | Novartis Buy | Deutsche Bank AG | |
| 10.08.23 | Novartis Underweight | Barclays Capital | |
| 19.07.23 | Novartis Buy | Deutsche Bank AG | |
| 19.07.23 | Novartis Neutral | JP Morgan Chase & Co. | |
Werbung
Werbung